Skip to main content
Top
Published in: Medical Oncology 1/2011

01-12-2011 | Case Report

Primary clear cell adenocarcinoma of the lung

Author: Tadashi Terada

Published in: Medical Oncology | Special Issue 1/2011

Login to get access

Abstract

Primary clear cell adenocarcinoma of the lung is extremely rare. A 63-year-old Japanese man consulted to our hospital because of cough and sputum. Imaging modalities including XP, CT and MRI revealed a tumor of the right middle lobe. They did not identify other tumors in the body. Because clinical cytology and biopsy showed malignant cells, segmentectomy of the lobe was performed. Grossly, the tumor was whitish tan tumor measuring 5 × 6 × 5 cm. Histologically, the tumor was composed entirely of clear cells arranged in papillary and tubular patterns. The tumor cells had hyperchromatic nuclei, and mitotic figure and nuclear stratification were scattered. Histochemically, glycogen and mucins were absent in tumor cell cytoplasm. Immunohistochemically, the tumor cells were positive for pancytokeratin (AE1/3, CAM5.2), cytokeratin (CK) 7, CK 8, CK18, CK19, EMA, CEA, CA19-9, CA125, p53, Ki-67 (labeling = 80%), TTF-1 and surfactant apoprotein A. In contrast, the tumor cells were negative for CK5/6, CK 34βE12, CK 14, CK 20, vimentin, desmin, S100 protein, α-smooth muscle actin, AFP, HMB45, CD10, CD34, HER2/neu, CD56, p63, and synaptophysin. The tumor recurred 6 months after the operation, and right middle lobectomy was performed. Postoperative imaging modalities showed no tumors. The patient is alive free from tumor 9 years after the first manifestation.
Literature
1.
go back to reference Travis WD, Blambilla E, Konrad Muller-Hermelink HK, Harris CC. WHO Classification of Tumours. Pathology and Genetics of tumours of the lung, pleuram thymus and heart. Lyon: IARC Press; 2004. Travis WD, Blambilla E, Konrad Muller-Hermelink HK, Harris CC. WHO Classification of Tumours. Pathology and Genetics of tumours of the lung, pleuram thymus and heart. Lyon: IARC Press; 2004.
3.
go back to reference Yamamoto T, Yazawa T, Ogata T, Akaogi E, Mitsui K. Clear cell carcinoma of the lung: a case report and review of the literature. Lung Cancer. 1993;10:101–6.CrossRef Yamamoto T, Yazawa T, Ogata T, Akaogi E, Mitsui K. Clear cell carcinoma of the lung: a case report and review of the literature. Lung Cancer. 1993;10:101–6.CrossRef
4.
go back to reference Iyoda A, Hiroshima K, Toyozaki T, Tsukamoto Y, Haga Y, Fujisawa T, Ohwada H. Clear cell adenocarcinoma with endobronchial polypoid growth. Pathol Int. 2000;50:979–83.PubMedCrossRef Iyoda A, Hiroshima K, Toyozaki T, Tsukamoto Y, Haga Y, Fujisawa T, Ohwada H. Clear cell adenocarcinoma with endobronchial polypoid growth. Pathol Int. 2000;50:979–83.PubMedCrossRef
5.
go back to reference Kitada M, Ozawa K, Saito K, Hayashi S, Miyokawa N, Sasajima T. Clear cell carcinoma of the lung. Gen Thrac Cardiovasc Surg. 2010;58:87–90.CrossRef Kitada M, Ozawa K, Saito K, Hayashi S, Miyokawa N, Sasajima T. Clear cell carcinoma of the lung. Gen Thrac Cardiovasc Surg. 2010;58:87–90.CrossRef
6.
go back to reference Terada T, Kawaguchi M, Furukawa K, Sekido Y. Osamura Y.Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.PubMedCrossRef Terada T, Kawaguchi M, Furukawa K, Sekido Y. Osamura Y.Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.PubMedCrossRef
7.
go back to reference Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271–5.PubMedCrossRef Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271–5.PubMedCrossRef
8.
go back to reference Burg G, Kempf W, Jaffe ES et al. In: LeBoit PE, Burg G, Weedon D, Sarasin A eds. World Health Organization Classification of Tumours. Pathology and genetics of skin tumor. Lyon: IAPC Press; 2006. pp198–199. Burg G, Kempf W, Jaffe ES et al. In: LeBoit PE, Burg G, Weedon D, Sarasin A eds. World Health Organization Classification of Tumours. Pathology and genetics of skin tumor. Lyon: IAPC Press; 2006. pp198–199.
Metadata
Title
Primary clear cell adenocarcinoma of the lung
Author
Tadashi Terada
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue Special Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9745-3

Other articles of this Special Issue 1/2011

Medical Oncology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.